COVID-19 Vaccine Discovery and Cold Chain Distribution Requirements
White Paper Nov 20, 2020
In the wave of COVID-19 research and distribution, can the current cold chain infrastructure support what is coming? As of November 16, according to the Treatment and Vaccine Tracker, there are 319 treatments and 234 vaccines in development. With some contenders showing promising results, it is paramount the cold chain distribution infrastructure is there to support scientists in their discovery.
Download this whitepaper to discover how automated sample storage is going to help COVID-19 research by:
- Avoiding thermal cycling stress
- Maximizing sample integrity
- Ensuring processes are scalable, consistent, and repeatable
Related White Papers
Download this case study to learn more about how Thermo Scientific Core LIMS™ and Core ELN™ software solutions are supporting efforts to develop the human microbiome into a new modality for drug development.
READ MOREDownload this whitepaper to learn more about digital technologies and how they are used in research for multiple industries.
READ MOREDownload this whitepaper to learn more about digital transformation and how its use can affect workflows.
READ MORELike what you just read? You can find similar content on the communities below.
Biopharma InformaticsTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE
